ArcticZymes AS Files New Enzyme Patent Application

Biotec Pharmacon subsidiary ArcticZymes AS has filed a priority application on a newly developed heat-labile endonuclease with outstanding properties. This new endonuclease features optimal activity at extremely high salt concentrations and is irreversibly inactivated by very gentle heat-treatment conditions. With this new enzyme it is for the first time possible to offer manufacturers and users of enzymes a convenient way …

ArcticZymes establishes US subsidiary

ArcticZymes AS announced today the formation of ArcticZymes Inc. a wholly owned subsidiary located in Plymouth Meeting, PA. ArcticZymes AS is a subsidiary of Biotec Pharmacon, focusing on enzymes for use in molecular biology and diagnostics. “The formation of a U.S. based subsidiary is a key milestone for our company and our B2B and OEM customers in North America. Our …

Extended collaboration between PrimerDesign and ArcticZymes

PrimerDesign and ArcticZymes AS 22 September 2011 announced an extension of the collaboration published June 2011. ArcticZymes AS will in the future supply their unique Cod UNG to PrimerDesign who will use Cod UNG to enhance the sensitivity and specificity of their Precision Mastermix product range. CodUNG is the only UNG enzyme that is fully inactivated by heat allowing the …